Kitazato is participating in the CBRA 2026 Pre-Congress Workshops and a symposium on Ultra-Fast Vitrification protocols.
Published
Signal category
Presence & Recognition
Quote
“And the Pre-Congress Workshops are not the only thing we have prepared for CBRA 2026!”
— Kitazato team
Company
Kitazato
Japanese corporation dedicated to research and development of medical devices for IVF.
- Industry
- Biotechnology
- Location
- Shizuoka, JP
- Company size
- 44 employees
Kitazato Corporation is a global company based in Japan, dedicated to the assisted reproductive technologies field. Since our foundation in 1996, we’ve been researching, developing and manufacturing medical devices and media to support a wide range of fertility treatments. Thanks to our strong distribution network, we’re able to cooperate with IVF clinics all over the world. During the last two decades, thousands of IVF professionals have placed their trust in one of our largest contributions to the field, The Cryotop®Method, making it the undisputable market leader in cryopreservation of human gametes. One of our main pillars is to offer quality, environmentally friendly and constantly improving devices, in collaboration with scientists, as a way to secure access to the latest technologies. We’re committed to offering all-year-round training programs to clinical embryologists and gynecologists in order to expand their knowledge and enhance the benefits that our products offer in their everyday procedures. For more information www.kitazato-ivf.com
Founded 1996